 | • レポートコード：MRC2-11QY08246 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：化学・材料 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はNSAID APIのグローバル市場について調査・分析したレポートです。種類別（パラセタモール、イブプロフェン、アスピリン、ナプロキセン、その他）市場規模、用途別（自社製造、受託製造）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別NSAID APIの競争状況、市場シェア ・世界のNSAID API市場：種類別市場規模 2015年-2020年（パラセタモール、イブプロフェン、アスピリン、ナプロキセン、その他） ・世界のNSAID API市場：種類別市場規模予測 2021年-2026年（パラセタモール、イブプロフェン、アスピリン、ナプロキセン、その他） ・世界のNSAID API市場：用途別市場規模 2015年-2020年（自社製造、受託製造） ・世界のNSAID API市場：用途別市場規模予測 2021年-2026年（自社製造、受託製造） ・北米のNSAID API市場分析：米国、カナダ ・ヨーロッパのNSAID API市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのNSAID API市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のNSAID API市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのNSAID API市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Novartis、Pfizer、Boehringer Ingelheim、Teva Pharmaceutical、BASF、Hospira、Lonza Group、Mylan、Aurobindo Pharma、Cambrex、Dr. Reddy's Laboratories、Actavis、Wuxi Apptec、Zhejiang NHU ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Active pharmaceutical ingredients (APIs) are bulk drug products that are used as raw materials for formulations. Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that groups together drugs that provide analgesic (pain-killing) and antipyretic (fever-reducing) effects, and, in higher doses, anti-inflammatory effects.
North America dominated the global NSAID API market due to high demand for APIs in drug formulations and research and development programs in this region. The region is expected to continue its dominance in the coming years owing to increasing preference for generic medicines as a result of high healthcare costs in the U.S. Among other regions, Asia-Pacific is the next largest market for APIs. This region has become the most attractive market due to clustering of a large number of generic medicine manufacturers.
Market Analysis and Insights: Global NSAID API Market
The global NSAID API market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global NSAID API Scope and Market Size
NSAID API market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global NSAID API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the NSAID API market is segmented into
Paracetamol
Ibuprofen
Aspirin
Naproxen
Others
Segment by Application, the NSAID API market is segmented into
Captive Manufacturing
Contract Manufacturing
Regional and Country-level Analysis
The NSAID API market is analysed and market size information is provided by regions (countries).
The key regions covered in the NSAID API market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and NSAID API Market Share Analysis
NSAID API market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in NSAID API business, the date to enter into the NSAID API market, NSAID API product introduction, recent developments, etc.
The major vendors covered:
Novartis
Pfizer
Boehringer Ingelheim
Teva Pharmaceutical
BASF
Hospira
Lonza Group
Mylan
Aurobindo Pharma
Cambrex
Dr. Reddy’s Laboratories
Actavis
Wuxi Apptec
Zhejiang NHU
1 Study Coverage
1.1 NSAID API Product Introduction
1.2 Market Segments
1.3 Key NSAID API Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global NSAID API Market Size Growth Rate by Type
1.4.2 Paracetamol
1.4.3 Ibuprofen
1.4.4 Aspirin
1.4.5 Naproxen
1.4.6 Others
1.5 Market by Application
1.5.1 Global NSAID API Market Size Growth Rate by Application
1.5.2 Captive Manufacturing
1.5.3 Contract Manufacturing
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global NSAID API Market Size, Estimates and Forecasts
2.1.1 Global NSAID API Revenue 2015-2026
2.1.2 Global NSAID API Sales 2015-2026
2.2 Global NSAID API, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global NSAID API Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global NSAID API Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global NSAID API Competitor Landscape by Players
3.1 NSAID API Sales by Manufacturers
3.1.1 NSAID API Sales by Manufacturers (2015-2020)
3.1.2 NSAID API Sales Market Share by Manufacturers (2015-2020)
3.2 NSAID API Revenue by Manufacturers
3.2.1 NSAID API Revenue by Manufacturers (2015-2020)
3.2.2 NSAID API Revenue Share by Manufacturers (2015-2020)
3.2.3 Global NSAID API Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by NSAID API Revenue in 2019
3.2.5 Global NSAID API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 NSAID API Price by Manufacturers
3.4 NSAID API Manufacturing Base Distribution, Product Types
3.4.1 NSAID API Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers NSAID API Product Type
3.4.3 Date of International Manufacturers Enter into NSAID API Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global NSAID API Market Size by Type (2015-2020)
4.1.1 Global NSAID API Sales by Type (2015-2020)
4.1.2 Global NSAID API Revenue by Type (2015-2020)
4.1.3 NSAID API Average Selling Price (ASP) by Type (2015-2026)
4.2 Global NSAID API Market Size Forecast by Type (2021-2026)
4.2.1 Global NSAID API Sales Forecast by Type (2021-2026)
4.2.2 Global NSAID API Revenue Forecast by Type (2021-2026)
4.2.3 NSAID API Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global NSAID API Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global NSAID API Market Size by Application (2015-2020)
5.1.1 Global NSAID API Sales by Application (2015-2020)
5.1.2 Global NSAID API Revenue by Application (2015-2020)
5.1.3 NSAID API Price by Application (2015-2020)
5.2 NSAID API Market Size Forecast by Application (2021-2026)
5.2.1 Global NSAID API Sales Forecast by Application (2021-2026)
5.2.2 Global NSAID API Revenue Forecast by Application (2021-2026)
5.2.3 Global NSAID API Price Forecast by Application (2021-2026)
6 North America
6.1 North America NSAID API by Country
6.1.1 North America NSAID API Sales by Country
6.1.2 North America NSAID API Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America NSAID API Market Facts & Figures by Type
6.3 North America NSAID API Market Facts & Figures by Application
7 Europe
7.1 Europe NSAID API by Country
7.1.1 Europe NSAID API Sales by Country
7.1.2 Europe NSAID API Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe NSAID API Market Facts & Figures by Type
7.3 Europe NSAID API Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific NSAID API by Region
8.1.1 Asia Pacific NSAID API Sales by Region
8.1.2 Asia Pacific NSAID API Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific NSAID API Market Facts & Figures by Type
8.3 Asia Pacific NSAID API Market Facts & Figures by Application
9 Latin America
9.1 Latin America NSAID API by Country
9.1.1 Latin America NSAID API Sales by Country
9.1.2 Latin America NSAID API Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America NSAID API Market Facts & Figures by Type
9.3 Central & South America NSAID API Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa NSAID API by Country
10.1.1 Middle East and Africa NSAID API Sales by Country
10.1.2 Middle East and Africa NSAID API Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa NSAID API Market Facts & Figures by Type
10.3 Middle East and Africa NSAID API Market Facts & Figures by Application
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description and Business Overview
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis NSAID API Products Offered
11.1.5 Novartis Related Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Description and Business Overview
11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Pfizer NSAID API Products Offered
11.2.5 Pfizer Related Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Corporation Information
11.3.2 Boehringer Ingelheim Description and Business Overview
11.3.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Boehringer Ingelheim NSAID API Products Offered
11.3.5 Boehringer Ingelheim Related Developments
11.4 Teva Pharmaceutical
11.4.1 Teva Pharmaceutical Corporation Information
11.4.2 Teva Pharmaceutical Description and Business Overview
11.4.3 Teva Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Teva Pharmaceutical NSAID API Products Offered
11.4.5 Teva Pharmaceutical Related Developments
11.5 BASF
11.5.1 BASF Corporation Information
11.5.2 BASF Description and Business Overview
11.5.3 BASF Sales, Revenue and Gross Margin (2015-2020)
11.5.4 BASF NSAID API Products Offered
11.5.5 BASF Related Developments
11.6 Hospira
11.6.1 Hospira Corporation Information
11.6.2 Hospira Description and Business Overview
11.6.3 Hospira Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Hospira NSAID API Products Offered
11.6.5 Hospira Related Developments
11.7 Lonza Group
11.7.1 Lonza Group Corporation Information
11.7.2 Lonza Group Description and Business Overview
11.7.3 Lonza Group Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Lonza Group NSAID API Products Offered
11.7.5 Lonza Group Related Developments
11.8 Mylan
11.8.1 Mylan Corporation Information
11.8.2 Mylan Description and Business Overview
11.8.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Mylan NSAID API Products Offered
11.8.5 Mylan Related Developments
11.9 Aurobindo Pharma
11.9.1 Aurobindo Pharma Corporation Information
11.9.2 Aurobindo Pharma Description and Business Overview
11.9.3 Aurobindo Pharma Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Aurobindo Pharma NSAID API Products Offered
11.9.5 Aurobindo Pharma Related Developments
11.10 Cambrex
11.10.1 Cambrex Corporation Information
11.10.2 Cambrex Description and Business Overview
11.10.3 Cambrex Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Cambrex NSAID API Products Offered
11.10.5 Cambrex Related Developments
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Description and Business Overview
11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novartis NSAID API Products Offered
11.1.5 Novartis Related Developments
11.12 Actavis
11.12.1 Actavis Corporation Information
11.12.2 Actavis Description and Business Overview
11.12.3 Actavis Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Actavis Products Offered
11.12.5 Actavis Related Developments
11.13 Wuxi Apptec
11.13.1 Wuxi Apptec Corporation Information
11.13.2 Wuxi Apptec Description and Business Overview
11.13.3 Wuxi Apptec Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Wuxi Apptec Products Offered
11.13.5 Wuxi Apptec Related Developments
11.14 Zhejiang NHU
11.14.1 Zhejiang NHU Corporation Information
11.14.2 Zhejiang NHU Description and Business Overview
11.14.3 Zhejiang NHU Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Zhejiang NHU Products Offered
11.14.5 Zhejiang NHU Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 NSAID API Market Estimates and Projections by Region
12.1.1 Global NSAID API Sales Forecast by Regions 2021-2026
12.1.2 Global NSAID API Revenue Forecast by Regions 2021-2026
12.2 North America NSAID API Market Size Forecast (2021-2026)
12.2.1 North America: NSAID API Sales Forecast (2021-2026)
12.2.2 North America: NSAID API Revenue Forecast (2021-2026)
12.2.3 North America: NSAID API Market Size Forecast by Country (2021-2026)
12.3 Europe NSAID API Market Size Forecast (2021-2026)
12.3.1 Europe: NSAID API Sales Forecast (2021-2026)
12.3.2 Europe: NSAID API Revenue Forecast (2021-2026)
12.3.3 Europe: NSAID API Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific NSAID API Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: NSAID API Sales Forecast (2021-2026)
12.4.2 Asia Pacific: NSAID API Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: NSAID API Market Size Forecast by Region (2021-2026)
12.5 Latin America NSAID API Market Size Forecast (2021-2026)
12.5.1 Latin America: NSAID API Sales Forecast (2021-2026)
12.5.2 Latin America: NSAID API Revenue Forecast (2021-2026)
12.5.3 Latin America: NSAID API Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa NSAID API Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: NSAID API Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: NSAID API Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: NSAID API Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key NSAID API Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 NSAID API Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. NSAID API Market Segments
Table 2. Ranking of Global Top NSAID API Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global NSAID API Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Paracetamol
Table 5. Major Manufacturers of Ibuprofen
Table 6. Major Manufacturers of Aspirin
Table 7. Major Manufacturers of Naproxen
Table 8. Major Manufacturers of Others
Table 9. Global NSAID API Market Size Growth Rate by Application 2020-2026 (K MT)
Table 10. Global NSAID API Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 11. Global NSAID API Sales by Regions 2015-2020 (K MT)
Table 12. Global NSAID API Sales Market Share by Regions (2015-2020)
Table 13. Global NSAID API Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global NSAID API Sales by Manufacturers (2015-2020) (K MT)
Table 15. Global NSAID API Sales Share by Manufacturers (2015-2020)
Table 16. Global NSAID API Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global NSAID API by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NSAID API as of 2019)
Table 18. NSAID API Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. NSAID API Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers NSAID API Price (2015-2020) (USD/MT)
Table 21. NSAID API Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers NSAID API Product Type
Table 23. Date of International Manufacturers Enter into NSAID API Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global NSAID API Sales by Type (2015-2020) (K MT)
Table 26. Global NSAID API Sales Share by Type (2015-2020)
Table 27. Global NSAID API Revenue by Type (2015-2020) (US$ Million)
Table 28. Global NSAID API Revenue Share by Type (2015-2020)
Table 29. NSAID API Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 30. Global NSAID API Sales by Application (2015-2020) (K MT)
Table 31. Global NSAID API Sales Share by Application (2015-2020)
Table 32. North America NSAID API Sales by Country (2015-2020) (K MT)
Table 33. North America NSAID API Sales Market Share by Country (2015-2020)
Table 34. North America NSAID API Revenue by Country (2015-2020) (US$ Million)
Table 35. North America NSAID API Revenue Market Share by Country (2015-2020)
Table 36. North America NSAID API Sales by Type (2015-2020) (K MT)
Table 37. North America NSAID API Sales Market Share by Type (2015-2020)
Table 38. North America NSAID API Sales by Application (2015-2020) (K MT)
Table 39. North America NSAID API Sales Market Share by Application (2015-2020)
Table 40. Europe NSAID API Sales by Country (2015-2020) (K MT)
Table 41. Europe NSAID API Sales Market Share by Country (2015-2020)
Table 42. Europe NSAID API Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe NSAID API Revenue Market Share by Country (2015-2020)
Table 44. Europe NSAID API Sales by Type (2015-2020) (K MT)
Table 45. Europe NSAID API Sales Market Share by Type (2015-2020)
Table 46. Europe NSAID API Sales by Application (2015-2020) (K MT)
Table 47. Europe NSAID API Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific NSAID API Sales by Region (2015-2020) (K MT)
Table 49. Asia Pacific NSAID API Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific NSAID API Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific NSAID API Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific NSAID API Sales by Type (2015-2020) (K MT)
Table 53. Asia Pacific NSAID API Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific NSAID API Sales by Application (2015-2020) (K MT)
Table 55. Asia Pacific NSAID API Sales Market Share by Application (2015-2020)
Table 56. Latin America NSAID API Sales by Country (2015-2020) (K MT)
Table 57. Latin America NSAID API Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa NSAID API Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America NSAID API Revenue Market Share by Country (2015-2020)
Table 60. Latin America NSAID API Sales by Type (2015-2020) (K MT)
Table 61. Latin America NSAID API Sales Market Share by Type (2015-2020)
Table 62. Latin America NSAID API Sales by Application (2015-2020) (K MT)
Table 63. Latin America NSAID API Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa NSAID API Sales by Country (2015-2020) (K MT)
Table 65. Middle East and Africa NSAID API Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa NSAID API Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa NSAID API Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa NSAID API Sales by Type (2015-2020) (K MT)
Table 69. Middle East and Africa NSAID API Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa NSAID API Sales by Application (2015-2020) (K MT)
Table 71. Middle East and Africa NSAID API Sales Market Share by Application (2015-2020)
Table 72. Novartis Corporation Information
Table 73. Novartis Description and Major Businesses
Table 74. Novartis NSAID API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 75. Novartis Product
Table 76. Novartis Recent Development
Table 77. Pfizer Corporation Information
Table 78. Pfizer Description and Major Businesses
Table 79. Pfizer NSAID API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 80. Pfizer Product
Table 81. Pfizer Recent Development
Table 82. Boehringer Ingelheim Corporation Information
Table 83. Boehringer Ingelheim Description and Major Businesses
Table 84. Boehringer Ingelheim NSAID API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 85. Boehringer Ingelheim Product
Table 86. Boehringer Ingelheim Recent Development
Table 87. Teva Pharmaceutical Corporation Information
Table 88. Teva Pharmaceutical Description and Major Businesses
Table 89. Teva Pharmaceutical NSAID API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 90. Teva Pharmaceutical Product
Table 91. Teva Pharmaceutical Recent Development
Table 92. BASF Corporation Information
Table 93. BASF Description and Major Businesses
Table 94. BASF NSAID API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 95. BASF Product
Table 96. BASF Recent Development
Table 97. Hospira Corporation Information
Table 98. Hospira Description and Major Businesses
Table 99. Hospira NSAID API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 100. Hospira Product
Table 101. Hospira Recent Development
Table 102. Lonza Group Corporation Information
Table 103. Lonza Group Description and Major Businesses
Table 104. Lonza Group NSAID API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 105. Lonza Group Product
Table 106. Lonza Group Recent Development
Table 107. Mylan Corporation Information
Table 108. Mylan Description and Major Businesses
Table 109. Mylan NSAID API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 110. Mylan Product
Table 111. Mylan Recent Development
Table 112. Aurobindo Pharma Corporation Information
Table 113. Aurobindo Pharma Description and Major Businesses
Table 114. Aurobindo Pharma NSAID API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 115. Aurobindo Pharma Product
Table 116. Aurobindo Pharma Recent Development
Table 117. Cambrex Corporation Information
Table 118. Cambrex Description and Major Businesses
Table 119. Cambrex NSAID API Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 120. Cambrex Product
Table 121. Cambrex Recent Development
Table 122. Dr. Reddy's Laboratories Corporation Information
Table 123. Dr. Reddy's Laboratories Description and Major Businesses
Table 124. Dr. Reddy's Laboratories NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 125. Dr. Reddy's Laboratories Product
Table 126. Dr. Reddy's Laboratories Recent Development
Table 127. Actavis Corporation Information
Table 128. Actavis Description and Major Businesses
Table 129. Actavis NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 130. Actavis Product
Table 131. Actavis Recent Development
Table 132. Wuxi Apptec Corporation Information
Table 133. Wuxi Apptec Description and Major Businesses
Table 134. Wuxi Apptec NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 135. Wuxi Apptec Product
Table 136. Wuxi Apptec Recent Development
Table 137. Zhejiang NHU Corporation Information
Table 138. Zhejiang NHU Description and Major Businesses
Table 139. Zhejiang NHU NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 140. Zhejiang NHU Product
Table 141. Zhejiang NHU Recent Development
Table 142. Global NSAID API Sales Forecast by Regions (2021-2026) (K MT)
Table 143. Global NSAID API Sales Market Share Forecast by Regions (2021-2026)
Table 144. Global NSAID API Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 145. Global NSAID API Revenue Market Share Forecast by Regions (2021-2026)
Table 146. North America: NSAID API Sales Forecast by Country (2021-2026) (K MT)
Table 147. North America: NSAID API Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Europe: NSAID API Sales Forecast by Country (2021-2026) (K MT)
Table 149. Europe: NSAID API Revenue Forecast by Country (2021-2026) (US$ Million)
Table 150. Asia Pacific: NSAID API Sales Forecast by Region (2021-2026) (K MT)
Table 151. Asia Pacific: NSAID API Revenue Forecast by Region (2021-2026) (US$ Million)
Table 152. Latin America: NSAID API Sales Forecast by Country (2021-2026) (K MT)
Table 153. Latin America: NSAID API Revenue Forecast by Country (2021-2026) (US$ Million)
Table 154. Middle East and Africa: NSAID API Sales Forecast by Country (2021-2026) (K MT)
Table 155. Middle East and Africa: NSAID API Revenue Forecast by Country (2021-2026) (US$ Million)
Table 156. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 157. Key Challenges
Table 158. Market Risks
Table 159. Main Points Interviewed from Key NSAID API Players
Table 160. NSAID API Customers List
Table 161. NSAID API Distributors List
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. NSAID API Product Picture
Figure 2. Global NSAID API Sales Market Share by Type in 2020 & 2026
Figure 3. Paracetamol Product Picture
Figure 4. Ibuprofen Product Picture
Figure 5. Aspirin Product Picture
Figure 6. Naproxen Product Picture
Figure 7. Others Product Picture
Figure 8. Global NSAID API Sales Market Share by Application in 2020 & 2026
Figure 9. Captive Manufacturing
Figure 10. Contract Manufacturing
Figure 11. NSAID API Report Years Considered
Figure 12. Global NSAID API Market Size 2015-2026 (US$ Million)
Figure 13. Global NSAID API Sales 2015-2026 (K MT)
Figure 14. Global NSAID API Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global NSAID API Sales Market Share by Region (2015-2020)
Figure 16. Global NSAID API Sales Market Share by Region in 2019
Figure 17. Global NSAID API Revenue Market Share by Region (2015-2020)
Figure 18. Global NSAID API Revenue Market Share by Region in 2019
Figure 19. Global NSAID API Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by NSAID API Revenue in 2019
Figure 21. NSAID API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global NSAID API Sales Market Share by Type (2015-2020)
Figure 23. Global NSAID API Sales Market Share by Type in 2019
Figure 24. Global NSAID API Revenue Market Share by Type (2015-2020)
Figure 25. Global NSAID API Revenue Market Share by Type in 2019
Figure 26. Global NSAID API Market Share by Price Range (2015-2020)
Figure 27. Global NSAID API Sales Market Share by Application (2015-2020)
Figure 28. Global NSAID API Sales Market Share by Application in 2019
Figure 29. Global NSAID API Revenue Market Share by Application (2015-2020)
Figure 30. Global NSAID API Revenue Market Share by Application in 2019
Figure 31. North America NSAID API Sales Growth Rate 2015-2020 (K MT)
Figure 32. North America NSAID API Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America NSAID API Sales Market Share by Country in 2019
Figure 34. North America NSAID API Revenue Market Share by Country in 2019
Figure 35. U.S. NSAID API Sales Growth Rate (2015-2020) (K MT)
Figure 36. U.S. NSAID API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada NSAID API Sales Growth Rate (2015-2020) (K MT)
Figure 38. Canada NSAID API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America NSAID API Market Share by Type in 2019
Figure 40. North America NSAID API Market Share by Application in 2019
Figure 41. Europe NSAID API Sales Growth Rate 2015-2020 (K MT)
Figure 42. Europe NSAID API Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe NSAID API Sales Market Share by Country in 2019
Figure 44. Europe NSAID API Revenue Market Share by Country in 2019
Figure 45. Germany NSAID API Sales Growth Rate (2015-2020) (K MT)
Figure 46. Germany NSAID API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France NSAID API Sales Growth Rate (2015-2020) (K MT)
Figure 48. France NSAID API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. NSAID API Sales Growth Rate (2015-2020) (K MT)
Figure 50. U.K. NSAID API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy NSAID API Sales Growth Rate (2015-2020) (K MT)
Figure 52. Italy NSAID API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia NSAID API Sales Growth Rate (2015-2020) (K MT)
Figure 54. Russia NSAID API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe NSAID API Market Share by Type in 2019
Figure 56. Europe NSAID API Market Share by Application in 2019
Figure 57. Asia Pacific NSAID API Sales Growth Rate 2015-2020 (K MT)
Figure 58. Asia Pacific NSAID API Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific NSAID API Sales Market Share by Region in 2019
Figure 60. Asia Pacific NSAID API Revenue Market Share by Region in 2019
Figure 61. China NSAID API Sales Growth Rate (2015-2020) (K MT)
Figure 62. China NSAID API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan NSAID API Sales Growth Rate (2015-2020) (K MT)
Figure 64. Japan NSAID API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea NSAID API Sales Growth Rate (2015-2020) (K MT)
Figure 66. South Korea NSAID API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India NSAID API Sales Growth Rate (2015-2020) (K MT)
Figure 68. India NSAID API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia NSAID API Sales Growth Rate (2015-2020) (K MT)
Figure 70. Australia NSAID API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan NSAID API Sales Growth Rate (2015-2020) (K MT)
Figure 72. Taiwan NSAID API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia NSAID API Sales Growth Rate (2015-2020) (K MT)
Figure 74. Indonesia NSAID API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand NSAID API Sales Growth Rate (2015-2020) (K MT)
Figure 76. Thailand NSAID API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia NSAID API Sales Growth Rate (2015-2020) (K MT)
Figure 78. Malaysia NSAID API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines NSAID API Sales Growth Rate (2015-2020) (K MT)
Figure 80. Philippines NSAID API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam NSAID API Sales Growth Rate (2015-2020) (K MT)
Figure 82. Vietnam NSAID API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific NSAID API Market Share by Type in 2019
Figure 84. Asia Pacific NSAID API Market Share by Application in 2019
Figure 85. Latin America NSAID API Sales Growth Rate 2015-2020 (K MT)
Figure 86. Latin America NSAID API Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America NSAID API Sales Market Share by Country in 2019
Figure 88. Latin America NSAID API Revenue Market Share by Country in 2019
Figure 89. Mexico NSAID API Sales Growth Rate (2015-2020) (K MT)
Figure 90. Mexico NSAID API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil NSAID API Sales Growth Rate (2015-2020) (K MT)
Figure 92. Brazil NSAID API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina NSAID API Sales Growth Rate (2015-2020) (K MT)
Figure 94. Argentina NSAID API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America NSAID API Market Share by Type in 2019
Figure 96. Latin America NSAID API Market Share by Application in 2019
Figure 97. Middle East and Africa NSAID API Sales Growth Rate 2015-2020 (K MT)
Figure 98. Middle East and Africa NSAID API Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa NSAID API Sales Market Share by Country in 2019
Figure 100. Middle East and Africa NSAID API Revenue Market Share by Country in 2019
Figure 101. Turkey NSAID API Sales Growth Rate (2015-2020) (K MT)
Figure 102. Turkey NSAID API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia NSAID API Sales Growth Rate (2015-2020) (K MT)
Figure 104. Saudi Arabia NSAID API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E NSAID API Sales Growth Rate (2015-2020) (K MT)
Figure 106. U.A.E NSAID API Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa NSAID API Market Share by Type in 2019
Figure 108. Middle East and Africa NSAID API Market Share by Application in 2019
Figure 109. North America NSAID API Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. North America NSAID API Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe NSAID API Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Europe NSAID API Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific NSAID API Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Asia Pacific NSAID API Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America NSAID API Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Latin America NSAID API Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa NSAID API Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. Middle East and Africa NSAID API Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
非ステロイド性抗炎症薬（NSAID）の世界市場（～2026年） Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and ki…- キャプティブ発電の世界市場（～2026年） Captive power generation is the power generation unit that has been set up by an industry or individual for its personal consumption. This might comprise a power generation unit or plant set up by a cooperative society or an association of people for the generation of power mainly for the use of its…
- パラセタモール消費の世界市場（～2026年） Market Analysis and Insights: Global Paracetamol Consumption Market The global Paracetamol Consumption market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Paracetamol Consumption Scope and Market Size Paracetamol Consumpti…
- アスピリン腸溶性コーティング錠の世界市場（～2026年） Market Analysis and Insights: Global Aspirin Enteric-Coated Tablets Market The global Aspirin Enteric-Coated Tablets market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Aspirin Enteric-Coated Tablets Scope and Market Size …
- PAP・パラセタモールの世界市場（～2026年） Paracetamol, also named acetaminophen, is an active ingredient in hundreds of over-the-counter (OTC) and prescription medicines. It relieves pain and fever. And, it is also combined with other active ingredients in medicines that treat allergy, cough, colds, flu, and sleeplessness. In the world the …